These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
205 related articles for article (PubMed ID: 28883898)
1. Upregulation of PSMD10 caused by the JMJD2A histone demethylase. Kim TD; Oh S; Lightfoot SA; Shin S; Wren JD; Janknecht R Int J Clin Exp Med; 2016; 9(6):10123-10134. PubMed ID: 28883898 [TBL] [Abstract][Full Text] [Related]
2. Histone demethylase JMJD2A drives prostate tumorigenesis through transcription factor ETV1. Kim TD; Jin F; Shin S; Oh S; Lightfoot SA; Grande JP; Johnson AJ; van Deursen JM; Wren JD; Janknecht R J Clin Invest; 2016 Feb; 126(2):706-20. PubMed ID: 26731476 [TBL] [Abstract][Full Text] [Related]
3. SET7/9-mediated methylation affects oncogenic functions of histone demethylase JMJD2A. Gu R; Kim TD; Song H; Sui Y; Shin S; Oh S; Janknecht R JCI Insight; 2023 Oct; 8(20):. PubMed ID: 37870957 [TBL] [Abstract][Full Text] [Related]
4. ETS transcription factor ERG cooperates with histone demethylase KDM4A. Kim TD; Shin S; Janknecht R Oncol Rep; 2016 Jun; 35(6):3679-88. PubMed ID: 27109047 [TBL] [Abstract][Full Text] [Related]
5. Oncogenic features of the JMJD2A histone demethylase in breast cancer. Berry WL; Shin S; Lightfoot SA; Janknecht R Int J Oncol; 2012 Nov; 41(5):1701-6. PubMed ID: 22948256 [TBL] [Abstract][Full Text] [Related]
6. Sumoylation of transcription factor ETV1 modulates its oncogenic potential in prostate cancer. Oh S; Shin S; Janknecht R Int J Clin Exp Pathol; 2021; 14(7):795-810. PubMed ID: 34367411 [TBL] [Abstract][Full Text] [Related]
7. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway. Zhang J; Li Q; Zhang S; Xu Q; Wang T Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893 [TBL] [Abstract][Full Text] [Related]
8. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer. Oh S; Song H; Freeman WM; Shin S; Janknecht R Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020 [TBL] [Abstract][Full Text] [Related]
9. Promotion of colorectal cancer by transcription factor BHLHE40 involves upregulation of Sui Y; Jiang H; Kellogg CM; Oh S; Janknecht R Front Oncol; 2023; 13():1122238. PubMed ID: 36890812 [TBL] [Abstract][Full Text] [Related]
10. Role of a 19S Proteasome Subunit- PSMD10 Sahu I; Nanaware P; Mane M; Mulla SW; Roy S; Venkatraman P Int J Stem Cells; 2019 Nov; 12(3):463-473. PubMed ID: 31474027 [TBL] [Abstract][Full Text] [Related]
11. Cooperation between ETS variant 2 and Jumonji domain‑containing 2 histone demethylases. Li X; Moon G; Shin S; Zhang B; Janknecht R Mol Med Rep; 2018 Apr; 17(4):5518-5527. PubMed ID: 29393482 [TBL] [Abstract][Full Text] [Related]
12. HistoneH3 demethylase JMJD2A promotes growth of liver cancer cells through up-regulating miR372. An J; Xu J; Li J; Jia S; Li X; Lu Y; Yang Y; Lin Z; Xin X; Wu M; Zheng Q; Pu H; Gui X; Li T; Lu D Oncotarget; 2017 Jul; 8(30):49093-49109. PubMed ID: 28467776 [TBL] [Abstract][Full Text] [Related]
13. A druggable pocket on PSMD10 M G MS; Chikhale R; Nanaware PP; Dalvi S; Venkatraman P Eur J Pharmacol; 2022 Jan; 915():174718. PubMed ID: 34953804 [TBL] [Abstract][Full Text] [Related]
14. The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. Zhang QJ; Chen HZ; Wang L; Liu DP; Hill JA; Liu ZP J Clin Invest; 2011 Jun; 121(6):2447-56. PubMed ID: 21555854 [TBL] [Abstract][Full Text] [Related]
15. A new isoform of the histone demethylase JMJD2A/KDM4A is required for skeletal muscle differentiation. Verrier L; Escaffit F; Chailleux C; Trouche D; Vandromme M PLoS Genet; 2011 Jun; 7(6):e1001390. PubMed ID: 21694756 [TBL] [Abstract][Full Text] [Related]
16. Histone demethylase JMJD2A regulates Kaposi's sarcoma-associated herpesvirus replication and is targeted by a viral transcriptional factor. Chang PC; Fitzgerald LD; Hsia DA; Izumiya Y; Wu CY; Hsieh WP; Lin SF; Campbell M; Lam KS; Luciw PA; Tepper CG; Kung HJ J Virol; 2011 Apr; 85(7):3283-93. PubMed ID: 21228229 [TBL] [Abstract][Full Text] [Related]
17. Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Shin S; Janknecht R Biochem Biophys Res Commun; 2007 Aug; 359(3):742-6. PubMed ID: 17555712 [TBL] [Abstract][Full Text] [Related]
18. Novel Nexus with NFκB, β-catenin, and RB1 empowers PSMD10/Gankyrin to counteract TNF-α induced apoptosis establishing its oncogenic role. Mulla SW; Venkatraman P Int J Biochem Cell Biol; 2022 May; 146():106209. PubMed ID: 35378311 [TBL] [Abstract][Full Text] [Related]
19. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression. Luo T; Fu J; Xu A; Su B; Ren Y; Li N; Zhu J; Zhao X; Dai R; Cao J; Wang B; Qin W; Jiang J; Li J; Wu M; Feng G; Chen Y; Wang H Autophagy; 2016 Aug; 12(8):1355-71. PubMed ID: 25905985 [TBL] [Abstract][Full Text] [Related]
20. The SKP1-Cul1-F-box and leucine-rich repeat protein 4 (SCF-FbxL4) ubiquitin ligase regulates lysine demethylase 4A (KDM4A)/Jumonji domain-containing 2A (JMJD2A) protein. Van Rechem C; Black JC; Abbas T; Allen A; Rinehart CA; Yuan GC; Dutta A; Whetstine JR J Biol Chem; 2011 Sep; 286(35):30462-30470. PubMed ID: 21757720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]